On Wednesday, the FDA approved Caraco Pharmaceutical Labs’ generic form of Mobic (meloxicam), made by Boeringher Ingelheim.
Meloxicam is a non-steroidal antiinflammitory drug (NSAID) used in the treatment of osteoarthritis and rheumatoid arthritis. It will be available in 7.5 and 15 mg tablets, with doses not to exceed 15 mg daily, due to serious GI problems.